THE USE OF ANTHROPOMETRIC MEASUREMENTS OF OBESITY IN PREDICTION OF MICROVASCULAR COMPLICATIONS IN OBESE TYPE 2 DIABETIC PATIENTS

被引:13
|
作者
Bulum, Tomislav [1 ,2 ]
Blaslov, Kristina [1 ]
Duvnjak, Lea [1 ,2 ]
机构
[1] Merkur Univ Hosp, Vuk Vrhovac Clin Diabet Endocrinol & Metab Dis, Dugi Dol 4a, HR-10000 Zagreb, Croatia
[2] Univ Zagreb, Sch Med, Zagreb, Croatia
关键词
Diabetes mellitus; type; 2; Obesity-complications; Waist circumference; Waist-height ratio; Renal insufficiency; chronic; Diabetic neuropathy; Diabetic retinopathy; TO-HEIGHT RATIO; CARDIOVASCULAR RISK-FACTORS; CHRONIC KIDNEY-DISEASE; BODY-MASS INDEX; ABDOMINAL ADIPOSITY; WAIST CIRCUMFERENCE; PIMA-INDIANS; WEIGHT-LOSS; ASSOCIATION; RETINOPATHY;
D O I
10.20471/acc.2016.55.02.06
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Waist circumference (WC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR) are superior to body mass index (BMI) in predicting type 2 diabetes mellitus (T2DM) development. The aim of this study was to investigate the predictive power of BMI, WC, WHR and WHtR for microvascular (chronic kidney disease (CKD), retinopathy and peripheral neuropathy) prevalence in obese (BMI >= 35 kg/m(2))T2DM patients. This cross-sectional study included 125 T2DM patients of both genders. The validity of each test was assessed by Receiver Operating Characteristic (ROC) curves; the area under the curve (AUC) was calculated for each anthropometric parameter and microvascular complication. AUCs for WHtR were significantly higher than AUCs for WC with respect to CKD. Optimal cut-off for WHtR was >0.593 and WC > 112 cm regarding CKD. The AUC for peripheral neuropathy was significant only for WHR and optimal cut-off for WHR was >1.409 with low sensitivity and high specificity Our study demonstrated that WHtR, WC and WHR might be used as simple and noninvasive methods for detection of CKD and peripheral neuropathy in obese T2DM population.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 50 条
  • [1] Visceral obesity is associated with microvascular complications in type 1 diabetic patients
    Rodrigues, Ticiana
    Milano, Stefano
    Jorge, Esteves
    Bastiani, Carlos E.
    Macedo, Bruno
    Kramer, Caroline
    Azevedo, Mirela
    Gross, Jorge L.
    Canani, Luis H.
    Pecis, Miriam
    DIABETES, 2008, 57 : A222 - A222
  • [2] Microvascular complications and risk factors in type 2 diabetic patients
    Canizo-Gomez, F. J.
    Fernandez-Perez, C.
    Pajuelo-Fernandez, F. J.
    DIABETOLOGIA, 2008, 51 : S488 - S489
  • [3] Prevalence of microvascular complications in type 2 diabetic patients with dyslipidemia
    Zeryouh, N.
    Messaoudi, N.
    Benyakhlef, S.
    Laalaoua, Y.
    Hamdane, C.
    Rouf, S.
    Latrech, H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [4] Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients
    Kerkeni, Mohsen
    Saidi, Amel
    Bouzidi, Hassan
    Letaief, Ahmed
    Ben Yahia, Salim
    Hammami, Mohamed
    DIABETES & VASCULAR DISEASE RESEARCH, 2013, 10 (03): : 239 - 245
  • [5] Use of Anthropometric Measures of Obesity to Predict Diabetic Retinopathy in Patients with Type 2 Diabetes in China
    Yi, Qiu-Xue
    Zhu, Li-Na
    Ma, Jing
    Yu, Xin-Jie
    Liu, Lin
    Shen, Jie
    DIABETES METABOLIC SYNDROME AND OBESITY, 2021, 14 : 4089 - 4095
  • [6] Effect of sodium glucose Co-transporter 2 inhibitor use on anthropometric measurements and blood glucose in obese and non-obese type 2 diabetic patients
    Dedemen, Busra
    Duman, Tuba Taslamacioglu
    Dedemen, Metin Mert
    Aktas, Gulali
    CLINICAL NUTRITION ESPEN, 2024, 63
  • [7] Relationship between inflammatory markers, metabolic and anthropometric variables in the Caribbean type 2 diabetic patients with and without microvascular complications
    Nayak B.S.
    Roberts L.
    Journal of Inflammation, 3 (1)
  • [8] The Significance of Anthropometric Indicators in the Prediction of Abdominal Obesity in Obese Patients
    Trnkova, Lubica
    CLINICAL SOCIAL WORK AND HEALTH INTERVENTION, 2019, 10 (04): : 25 - 32
  • [9] Gait Alterations and Microvascular Chronic Complications in Type 2 Diabetic Patients
    Iacopi, Elisabetta
    Giannarelli, Rosa
    Coppelli, Alberto
    Abbruzzese, Lorenza
    Venturi, Martina
    Lamola, Giuseppe
    Martelli, Dario
    Chisari, Carmelo
    Piaggesi, Alberto
    DIABETES, 2014, 63 : A168 - A168
  • [10] Use of insulin in Type 2 patients with microvascular complications.
    Gfrerer, RJ
    Rakovac, I
    Habacher, W
    Seereiner, S
    Beck, P
    Jeitler, K
    Moser, R
    Risse, A
    Jecht, M
    Mrak, P
    Pieber, TR
    DIABETOLOGIA, 2003, 46 : A428 - A429